Find an expert

Prof David Ascher is an NHMRC Investigator Leadership Fellow and Deputy Associate Dean (Research Partnerships) in the Faculty of Science at The University of Queensland. He also serves as Deputy Director of the Australian Centre for Ecogenomics and Head of Computational Biology & Clinical Informatics at the Baker Heart and Diabetes Institute. Internationally, he sits on scientific advisory boards for A*STAR (Singapore), Fiocruz (Brazil) and the Tuscany University Network (Italy), and has been recognised with major honours including the Royal Society of Chemistry Horizon Prize.

A global leader in computational biology and personalised medicine, Prof Ascher develops advanced AI- and structure-based approaches to understand how genetic variation alters protein structure, function, and clinical outcomes. His group has built one of the world’s most widely used platforms for interpreting coding variants—over 90 computational tools, accessed more than 9.5 million times per year from 120+ countries. These tools underpin clinical diagnostics, guide drug development pipelines, and support international public-health responses to antimicrobial resistance and emerging infectious diseases.

His research has led to new molecular insights across infectious disease, rare disease, oncology and cardiometabolic health, and has been translated directly into practice—informing WHO policy, enabling early resistance detection in tuberculosis and leprosy, stratifying patients with hereditary cancers, and supporting vaccine design with partners including Pfizer. Many of his methods are embedded in globally used resources such as Ensembl VEP, PDBe, and the EMBL-EBI KnowledgeBase.

Prof Ascher has a longstanding commitment to interdisciplinary leadership and capability-building across UQ. As Director (Strategy) of the Biotechnology Programs and later as Deputy Associate Dean (Research Partnerships), he has driven initiatives to transform UQ’s biotechnology education, grow industry-embedded training, expand international partnerships, and diversify research income. He has led the development of UQ’s biotechnology–industry placement ecosystem, initiated new professional development programs adopted across multiple Faculties and Institutes, and established major collaborations with government, industry and global research organisations.

He has published more than 250 peer-reviewed papers (over half as senior author: FWCI 2.7), secured more than $30M in competitive research funding, and supervised over 60 HDR students who now hold leadership positions in academia, industry and government. His work appears in leading journals including Nature, Nature Genetics, Science, PNAS and Nature Microbiology, and is cited in over 100 policy documents and 40 patents.

Prof Ascher holds degrees in Biotechnology, Biochemistry, Structural Biology and Law. His research career has spanned Adelaide, Melbourne, Cambridge and Brisbane. After his PhD with Professor Michael Parker, he worked with Sir Tom Blundell at the University of Cambridge, where he led programs in structure-guided drug discovery and protein–protein interaction targeting. He established his independent laboratory at Cambridge and then at the University of Melbourne/Bio21 Institute, before moving to the Baker Institute in 2019 and joining UQ in 2021.

Scott Beatson is an Associate Professor and NHMRC Career Development Fellow at The University of Queensland (UQ). He specializes in bacterial pathogenomics: using whole-genome sequencing to investigate transmission, pathogenesis and antibiotic resistance in bacteria. Recent work from his group includes genomic analyses of pandrug resistant enterobacteriaceae and the multidrug resistant Escherichia coli ST131 pandemic clone. He was awarded a PhD from UQ for his work in bacterial pathogenesis in 2002 and developed his career in bacterial genomics in the United Kingdom with the support of fellowships from the Royal Commission for the Exhibition of 1851 (University of Oxford) and the UK Medical Research Council (University of Birmingham). Since returning to Australia he has held fellowships from both the NHMRC and ARC and has led a successful research group in the School of Chemistry and Molecular Biosciences at UQ since 2008. He is also a member of the Australian Infectious Diseases Research Centre and the Australian Centre for Ecogenomics. In 2016 he received the Frank Fenner Award from the Australian Society for Microbiology in recognition of his contribution to microbiology research in Australia.

Dr. Bialasiewicz worked at the Royal Children's Hospital and the Children's Health Queensland HHS for over 18 years conducting translational research and clinical support centering on infectious disease (primarily viral and bacterial) molecular diagnostics, general microbiology and molecular epidemiology. In 2019, he became a group leader at The University of Queensland's Australian Centre for Ecogenomics, expanding on a growing interest in the microbial ecology of the human body, it's role in health and disease, and ways to manipulated to achieve desirable outcomes. One Health microbial ecology, where human health is interconnected with the health of animals (both livestock and wildlife), and the broader environment is also an area of active interest. His background in virology has influenced the work he does, meaning a key focus of his microbial ecology works centres around the interactions between all types of microorgansims (bacteria, archaea, viruses, fungi, and micro-eukaryotes).

Ongoing work includes:

- Leveraging of emerging technologies to explore the hidden microbial diversity and their interactions in the human body.

- Using the technology to develop microbial (e.g. phage)-based treatments or preventatives to complex diseases (e.g. Otitis Media, Chronic Rhinosinusitis, GvHD).

- Understanding the genetics of antibiotic resistance spread.

Dr Chan has a PhD in Genomics and Computational Biology from UQ. He underwent postdoctoral training at Rutgers University (USA) in algal genomics and evolution. He returmed to UQ in late 2011 as one of the inaugural Great Barrier Reef Foundation Bioinformatics Fellows.

Dr Chan joined the School of Chemistry and Molecular Biosciences in 2020 as a group leader at the Australian Centre for Ecogenomics (ACE). His group uses advanced computational approaches to study genome evolution and develop scalable approaches for comparative genomics.

Paul Dennis leads an exciting research group that applies cutting-edge technologies to understand the roles of microorganisms and their responses to environmental change.

He is also a passionate educator and public speaker who advocates for the importance of biological diversity and evidence-based environmental awareness. He has talked about his research on ABC Radio and a range of other media outlets.

His teaching covers aspects of ecology, microbiology, plant and soil science, and climatology. He considers these topics to be of fundamental importance for the development of more sustainable societies and takes pride in helping others to obtain the knowledge and skills they need to build a better future.

Paul's research has taken him to Antarctica, the Amazon Rainforest, high mountains and oceans. The approaches used in his lab draw on a wide range of expertise in molecular biology, ecology, statistics, computer science, advanced imaging and soil science. He applies these skills to a wide-range of topics and systems including plant-microbe interactions, Antarctic marine and terrestrial ecology, biogeography, pollution and human health.

Dr Pingping Han is currently leading the Epigenetic Nanodiagnostics and Therapeutics Group within the Centre for Orofacial Regeneration, Reconstruction and Rehabilitation (COR3), at the UQ School of Dentistry. Dr Han received her PhD in Biomedical Engineering from the Queensland University of Technology (QUT) in 2014. Dr Han's current research focuses on three themes: a) salivary diagnostics for periodontal disease, b) “cell-free” regenerative therapy for periodontal tissue engineering and c) cellular nano-mechanics on different modified biomaterial substrates.

A/Prof Landsberg's undergraudate and Honours studies, majoring in Chemistry, were completed at Central Queensland University and the CSIRO (JM Rendel laboratories) before he moved to the University of Queensland to study a PhD in Biochemistry (awarded 2003). He then moved to a postdoctoral position at the Institute for Molecular Bioscience, spending time as a Visiting Scientist at Harvard Medical School (2008) and securing promotion to Senior Research Officer upon his return to IMB in 2009. He additioanlly spent time as a Visiting Scientist at the Victor Chang Cardiac Research Institute in 2010 and 2011.

In 2016, he joined UQ's School of Chemistry and Molecular Biosciences as a Group Leader in Cryo-EM and Macromolecular Structure and Senior Lecturer in Biochemistry and Biophysics, where he was promoted to Associate Professor in 2019. He has secured >$13.5M in competitive research funding since 2012, including major grants from the Australian Research Council and National Health and Medical Research Council. He his research has been presented at over 70 national and international conferences and research institutions.

Senior Research Fellow at IMB, University of Queensland in the field of novel antimicrobial discovery, mode of action studies and development. Studying the use of antibiotic-fluorescent probes for detetcing bacterial infections and resistance development.

Previously, a postdoctoral researcher at the Sir William Dunn School of Pathology, University Oxford. Studying dynamics of bacterial cell death during plasmid loss and post segregational killing using single cell approach of microfluidics and fluorescence microscopy.

Strong research professional with a Master of Science (M.Sc.) and Bachelor of Science (Hons) degree in Microbiology from University of Delhi, India and a PhD in Biomedical science and Biochemistry from The Australian National University, Canberra, Australia.

Skilled expertise in Microbiology, Biochemistry, Immunology, Molecular Biology, Cellular Biology, and Bioinformatics.

I have a keen interest in the evolutionary relationships that underpin symbioses, particularly those involved in plant disease. There are countless examples of how diseases have impacted on different crops throughout history, and this is an ongoing issue that deleteriously impacts food security. My research involves developing a better understanding of the epidemiology of plant diseases and pests, and delivering improved diagnostics and field management. Working with collaborators and international experts, my work involves research on a broad range of plants that are affected by bacteria, fungi, oomycetes and viruses. I have a strong interest in the biotic factors that govern soil health and the methods by which we can promote the development of beneficial microbial communities.